decentralized-studies-icta

Decentralised studies

Our three-fold expertise in the regulatory, digital, and logistics fields makes ICTA a partner of choice to conduct decentralised or hybrid studies.

We will advise you on the best set of solutions to choose to make your project feasible and optimize it.

arrow icta

– 2000 –

ALWAYS A STEP AHEAD AND WELL BEFORE DECENTRALISED STUDIES…
ICTA MOVES INTO THE DIGITAL AGE

For over 20 years, ICTA has been developing web-based digital tools dedicated to

the management of clinical studies

THE MANAGEMENT OF CLINICAL STUDIES

i-TMS, eREPORT, i-COM, IWRS/RTSM

Tools validated according to 21 CFR Part 11, GAMP 5, and ISO 27001 and 9001 standards

THE SECURE COLLECTION OF CLINICAL DATA

eCRF fully integrated in Data Management activities, ePRO, eDiary, eCOA… hosted in our servers in France

Collected data anonymized or pseudonymised in accordance with CNIL and GDPR requirements

arrow icta

– 2016 –

DEVELOPMENT OF NEW DIGITAL SOLUTIONS

As 2016 onwards, new digital solutions dealing with personal data appear in the e-health sphere:

Connected objects

Connected objects

Electronic consents

Electronic consents

Video consultations

Video consultations

Electronic and share medical records

Electronic and share medical records

– 2018 –

The implementation of GDPR regulates the processing of personal data.

arrow icta

– 2020 –

COVID19 PANDEMIC BOOSTS THE DIGITALISATION OF CLINICAL TRIALS

covid 19 pandemic boosts the digitalisation of clinical trials

With the COVID-19 pandemic, the need for continued patient care has encouraged the use of these digital solutions, and, as a consequence, their use in clinical studies:

  • Patient recruitment
  • Information on the study and signature of informed consents
  • Follow-up visits as scheduled in the protocol
  • Dispensing of study treatments
  • Remote monitoring of clinical data

– AT THE SAME TIME –

At the same time, since 2020, the ANSM and the EMA have been adopting new positions and have been publishing guidelines for the implementation of decentralised studies and the use, under certain conditions, of these digital tools. These guides, which are regularly updated, define a regulatory framework that we integrate in our developments.

arrow icta

– 2021 –

ICTA, PARTNER OF CHOICE
FOR YOUR DECENTRALISED STUDIES

Developing digital solutions requires the support of a wide range of expertise. This is why ICTA’s IT department has entered into strategic partnerships and offers a complete range of secure, configurable and easy-to-use solutions, enabling the full or partial decentralisation of your clinical studies in compliance with the regulations in force.

Electronic consents

Electronic consents

Teleconsultation

Teleconsultation

Telemonitoring
(secure file sharing)

Telemonitoring
(secure file sharing)

These applications process directly identifiable sensitive data, and guarantee the secure management of your clinical studies (validated tools, GDPR compliance, data stored in health data hosting companies). Tested during the pandemic period, they facilitate close monitoring of investigational sites and patients, real-time control of data and their rapid analysis.

These effective technical tools are of course only fully effective if backed up by responsive, experienced and supportive operational teams. The new digital solutions are tools that facilitate clinical research and the follow-up of patients in their healthcare journey. They offer real opportunities in cases where the feasibility of traditional approaches is limited.

DIGITAL SOLUTIONS

PROJECT
MANAGEMENT

i-TMS
eREPORT

SECURE
COMMUNICATION

i-COM

RANDOMISATION /
TRIAL SUPPLY MANAGEMENT

IWRS / RTSM

DECENTRALISED CLINICAL TRIALS WILL INCREASE

ICTA is at the forefront of technology by offering a range of secure solutions, ensuring data protection and consistency.

DATA COLLECTION

e-CRF / e-PRO

Connected tools

DIGITAL
SOLUTIONS

Patient enrollment

Patient information

Electronic consent

Teleconsultation

Telemonitoring

Built on decades of operational experience and extensive therapeutic experience, ICTA can assist you in navigating the assessment, the planning and execution of decentralised and hybrid clinical trials.

OTHER AREAS OF EXPERTISE

Clinical development

Clinical development

Choose the best clinical strategy with the help of our seasoned clinical drug development experts.…

Early access

Early access

ICTA set up a department dedicated to the conduct of Early Access and Compassionate Use…

Real World Evidence

Real World Evidence

With a large experience in health data assessments, ICTA teams are able to define the…

Health data analysis

Health data analysis

Today we have access to increasingly large data sources. Advanced technologies surch as Artificial Intelligence…

Biotech

Biotech

You are a biotech scouting for the right partner to support your clinical development ?…

Medical device

Medical device

Experienced in the regulatory requirements for clinical investigations of medical and in-vitro diagnostic devices, we…

Decentralised studies

Decentralised studies

Our three-fold expertise in the regulatory, digital, and logistics fields makes ICTA a partner of…

RGPD compliant
21 CFR Part 11 compliance
crédit d'impôt recherche
bureau veritas certification icta
bureau veritas certification icta